Bioceres Crop Solutions Corp.(BIOX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,790 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
BIOX Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Bioceres Crop Solutions Corp. (BIOX), a Materials sector company. 13F Pro's AI-powered ranking engine scores BIOX at 19.7/100 on a 32-signal composite quality model, placing it at rank #2,790 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (4.2) and institutional flow (5.4), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q4 2025), Bioceres Crop Solutions Corp. reports quarterly revenue of $65.3M, net income of $-182.5M. Top institutional holders of BIOX by reported 13-F value include Solel Partners, MIRAE ASSET GLOBAL ETFS Ltd., Long Focus Capital Management, based on the most recent SEC filings. BIOX trades on the Nasdaq exchange and files with the SEC under CIK 1769484. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BIOX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Bioceres Crop Solutions Corp. directly from SEC EDGAR. Bioceres Crop Solutions Corp.'s 13F Pro composite quality score has ranged between 20 and 54 since 2023, currently 19.7 — a declining long-term trajectory across 56 quarterly and live scoring snapshots.
Revenue
Q4 2025
$65.3M
Net Income
Q4 2025
$-182.5M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-27.9% YoYTotal Assets
-10.4% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $335.1M -27.9% | $464.8M +10.6% | $420.1M +25.4% | $334.8M +59.8% | $209.5M +21.0% | $173.1M |
| Total Assets | $763.6M -10.4% | $852.5M +4.2% | $818.1M +57.9% | $518.2M +31.3% | $394.6M +32.6% | $297.6M |
Get alerted when BIOX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Bioceres Crop Solutions Corp. including:
Top Institutional Holders of BIOX
Solel Partners LP
$1.6M4,579,364 shMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
$492.3K1,406,223 shLong Focus Capital Management, LLC
$290.5K829,748 shARDSLEY ADVISORY PARTNERS LP
$166.3K475,000 shUBS Group AG
$142.9K408,276 shSUSQUEHANNA INTERNATIONAL GROUP, LLP
$74.5K212,930 shCITADEL ADVISORS LLC
$59.3K169,500 shPNC FINANCIAL SERVICES GROUP, INC.
$46.5K133,000 shGOLDMAN SACHS GROUP INC
$45.3K129,445 shPING CAPITAL MANAGEMENT, INC.
$19.3K55,000 sh
| Fund | Value | Shares |
|---|---|---|
| Solel Partners LP | $1.6M | 4,579,364 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $492.3K | 1,406,223 |
| Long Focus Capital Management, LLC | $290.5K | 829,748 |
| ARDSLEY ADVISORY PARTNERS LP | $166.3K | 475,000 |
| UBS Group AG | $142.9K | 408,276 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $74.5K | 212,930 |
| CITADEL ADVISORS LLC | $59.3K | 169,500 |
| PNC FINANCIAL SERVICES GROUP, INC. | $46.5K | 133,000 |
| GOLDMAN SACHS GROUP INC | $45.3K | 129,445 |
| PING CAPITAL MANAGEMENT, INC. | $19.3K | 55,000 |
Companies Similar to BIOX
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Sibanye Stillwater Ltd
AMERICAN VANGUARD CORP
Caesarstone Ltd.
MERCER INTERNATIONAL INC.
RAYONIER ADVANCED MATERIALS INC.
Trekor Metals Ltd
Cellectis S.A.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Materials Companies
View all Materials →Put BIOX on your watchlist
Track score changes the day Bioceres Crop Solutions Corp. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is BIOX a good stock to buy?
13F Pro's AI-powered analysis of Bioceres Crop Solutions Corp. (BIOX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Materials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for BIOX are available on the BIOX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. BIOX is classified as a small company.
Which hedge funds own BIOX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling BIOX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Bioceres Crop Solutions Corp.'s investment landscape.